vasculature. These
treatments, though
effective in managing malignancies, pose significant risks
Asadullina, D.D.,
Gilyazova, I.R.,
Ivanova, E.A.,
Izmailova, S.M.,
Gilyazova, G.R.,
Pavlov, V.N.,
Khusnutdinova, E.K. (2024) RNA-146a can be used to create a panel of molecular markers for
evaluating the
effectiveness of immune
Klen, E.E.,
Nikitina, I.L.,
Khaliullin, F.A.,
Shepilova, S.O.,
Nikitina, E.A.,
Gaisina, G.G.,
Samorodov, A.V.,
Pavlov, V.N. (2024) , tumorigenicity, reproductive
effects, irritating
effects), low toxicity (class IV-V), and acceptable oral